Activity/assessment | Staff member | Approx. time to complete | T-1 | T0 | T1 | T2 | T3 | F1 | F2 |
Screening/ consent | Baseline assessment/ randomisation | Start intervention | End intervention | Postintervention assessment | 6-month follow-up | 1-year follow-up | |||
Enrolment | |||||||||
Eligibility screen | Study coordinator | 5 min | X | ||||||
Informed consent | Study coordinator | 5 min | X | ||||||
Randomisation | Study coordinator | 5 min | X | ||||||
Interventions | |||||||||
Exercise training | CEPs | 30 min per session | |||||||
Usual care | N/A | N/A | |||||||
Assessments | |||||||||
Demographic/ behavioural/ medical variables | Study coordinator | 5 min | X | ||||||
Primary outcome | |||||||||
Cardiorespiratory fitness | CEPs | 20 min | X | X | |||||
Secondary outcomes | |||||||||
Physical function/ anthropometrics | CEPs | 20 min | X | X | |||||
Blood biomarkers | Lab technicians | 3-4 hour | X | X | |||||
PSA | Lab technicians | 15 min | X | X | X | X | |||
Patient-reported outcomes | Study coordinator | 30 min | X | X | X | X | |||
Exploratory outcomes | |||||||||
Clinical events | Study coordinator | 5 min | X | X | X | X |
CEP, clinical exercise physiologist; PSA, prostate specific antigen.